223 related articles for article (PubMed ID: 11755227)
1. Zonisamide has beneficial effects on Parkinson's disease patients.
Murata M; Horiuchi E; Kanazawa I
Neurosci Res; 2001 Dec; 41(4):397-9. PubMed ID: 11755227
[TBL] [Abstract][Full Text] [Related]
2. Novel therapeutic effects of the anti-convulsant, zonisamide, on Parkinson's disease.
Murata M
Curr Pharm Des; 2004; 10(6):687-93. PubMed ID: 14965331
[TBL] [Abstract][Full Text] [Related]
3. Effect of zonisamide co-administration with levodopa on global gene expression in the striata of rats with Parkinson's disease.
Ueda Y; Tokashiki S; Kanemaru A; Kojima T
Biochem Biophys Res Commun; 2012 Nov; 428(3):401-4. PubMed ID: 23103374
[TBL] [Abstract][Full Text] [Related]
4. Zonisamide improves wearing-off in Parkinson's disease: A randomized, double-blind study.
Murata M; Hasegawa K; Kanazawa I; Fukasaka J; Kochi K; Shimazu R;
Mov Disord; 2015 Sep; 30(10):1343-50. PubMed ID: 26094993
[TBL] [Abstract][Full Text] [Related]
5. Zonisamide cotreatment delays striatal dopamine transporter reduction in Parkinson disease: A retrospective, observational cohort study.
Ikeda K; Yanagihashi M; Miura K; Ishikawa Y; Hirayama T; Takazawa T; Kano O; Kawabe K; Mizumura N; Iwasaki Y
J Neurol Sci; 2018 Aug; 391():5-9. PubMed ID: 30103971
[TBL] [Abstract][Full Text] [Related]
6. Combination Therapy with Zonisamide and Antiparkinson Drugs for Parkinson's Disease: A Meta-Analysis.
Matsunaga S; Kishi T; Iwata N
J Alzheimers Dis; 2017; 56(4):1229-1239. PubMed ID: 28157097
[TBL] [Abstract][Full Text] [Related]
7. Zonisamide: a new drug for Parkinson's disease.
Murata M
Drugs Today (Barc); 2010 Apr; 46(4):251-8. PubMed ID: 20502722
[TBL] [Abstract][Full Text] [Related]
8. Zonisamide ameliorates levodopa-induced dyskinesia and reduces expression of striatal genes in Parkinson model rats.
Oki M; Kaneko S; Morise S; Takenouchi N; Hashizume T; Tsuge A; Nakamura M; Wate R; Kusaka H
Neurosci Res; 2017 Sep; 122():45-50. PubMed ID: 28577977
[TBL] [Abstract][Full Text] [Related]
9. [The discovery of an antiparkinsonian drug, zonisamide].
Murata M
Rinsho Shinkeigaku; 2010 Feb; 50(2):67-73. PubMed ID: 20196486
[TBL] [Abstract][Full Text] [Related]
10. [Effect of zonisamide on resting tremor resistant to antiparkinsonian medication].
Nakanishi I; Kohmoto J; Miwa H; Kondo T
No To Shinkei; 2003 Aug; 55(8):685-9. PubMed ID: 13677302
[TBL] [Abstract][Full Text] [Related]
11. Novel dopamine releasing response of an anti-convulsant agent with possible anti-Parkinson's activity.
Gluck MR; Santana LA; Granson H; Yahr MD
J Neural Transm (Vienna); 2004 Jun; 111(6):713-24. PubMed ID: 15168218
[TBL] [Abstract][Full Text] [Related]
12. [Therapy of Parkinson's disease--up to date].
Murata M
Rinsho Shinkeigaku; 2008 Nov; 48(11):986-8. PubMed ID: 19198140
[TBL] [Abstract][Full Text] [Related]
13. [Discovery of an antiparkinsonian drug: zonisamide].
Murata M
Rinsho Shinkeigaku; 2010 Nov; 50(11):780-2. PubMed ID: 21921440
[TBL] [Abstract][Full Text] [Related]
14. [Pharmacologic treatment of Parkinson disease].
Murata M
Brain Nerve; 2009 Apr; 61(4):464-72. PubMed ID: 19378816
[TBL] [Abstract][Full Text] [Related]
15. Pramipexole vs levodopa as initial treatment for Parkinson disease: A randomized controlled trial. Parkinson Study Group.
Parkinson Study Group
JAMA; 2000 Oct; 284(15):1931-8. PubMed ID: 11035889
[TBL] [Abstract][Full Text] [Related]
16. Ropinirole in the treatment of levodopa-induced motor fluctuations in patients with Parkinson's disease.
Rascol O; Lees AJ; Senard JM; Pirtosek Z; Montastruc JL; Fuell D
Clin Neuropharmacol; 1996 Jun; 19(3):234-45. PubMed ID: 8726542
[TBL] [Abstract][Full Text] [Related]
17. Zonisamide enhances delta receptor-associated neurotransmitter release in striato-pallidal pathway.
Yamamura S; Ohoyama K; Nagase H; Okada M
Neuropharmacology; 2009 Sep; 57(3):322-31. PubMed ID: 19482038
[TBL] [Abstract][Full Text] [Related]
18. Zonisamide: a review of the clinical and experimental evidence for its use in Parkinson's disease.
Grover ND; Limaye RP; Gokhale DV; Patil TR
Indian J Pharmacol; 2013; 45(6):547-55. PubMed ID: 24347760
[TBL] [Abstract][Full Text] [Related]
19. Zonisamide for the treatment of Parkinson's disease.
Miwa H
Expert Rev Neurother; 2007 Sep; 7(9):1077-83. PubMed ID: 17868006
[TBL] [Abstract][Full Text] [Related]
20. Controversies in the therapy of Parkinson's disease.
Fahn S
Adv Neurol; 1996; 69():477-86. PubMed ID: 8615168
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
